Skip to main content

Global
Regions
WHO Regional websites
Countries
- Albania
- Andorra
- Armenia
- Austria
- Azerbaijan
- Belarus
- Belgium
- Bosnia and Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czechia
- Denmark
- Estonia
- Finland
- France
- Georgia
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Israel
- Italy
- Kazakhstan
- Kyrgyzstan
- Latvia
- Lithuania
- Luxembourg
- Malta
- Monaco
- Montenegro
- Netherlands (Kingdom of the)
- North Macedonia
- Norway
- Poland
- Portugal
- Republic of Moldova
- Romania
- Russian Federation
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Tajikistan
- Türkiye
- Turkmenistan
- Ukraine
- United Kingdom of Great Britain and Northern Ireland
- Uzbekistan

When autocomplete results are available use up and down arrows to review and enter to select.

Select language

Home

Health topics

All topics
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Resources

Popular

Our work

Our work

Policies

Flagship initiatives

Core priorities

Newsroom

Newsroom

Headlines

Data

Data at WHO/Europe

Highlights
- News
- Events
- Publications

About us

The European Health Report 2024

Emergencies

Focus on

Our work in emergencies

Health emergencies in the Region
- Health emergencies list

Ukraine emergency

About us

About WHO Europe

Governance
- Regional Committee for Europe
- Standing Committee

Partnerships

Second European Programme of Work

Home
Multimedia
item
Reflections on the markets for innovative medicines in the WHO European Region

Reflections on the markets for innovative medicines in the WHO European Region

13 February 2022

| video (webinar)

WHO Team

Access to Medicines and Health Products (AMP), Division of Health Systems (DHS)

Quick links
- Media centre
- Emergencies
About us
Help

Subscribe to our newsletters

Privacy Legal Notice

© 2026